drugset / Trial / NCT00306150
Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess if aprotinin (BAYA0128), given intravenously during your surgery, is safe and can help reduce the need for a blood transfusion during bladder surgery.
Timeline
- Start
- 2005-12
- Primary completion
- —
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprotinin | Unknown | 500000 unknown | Intravenous |
Indications
No indication recorded.